MI
IMMU

Markston International’s Immunomedics Inc IMMU Stock Holding History

Markston International’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-300
Closed -$1K – 207
2015
Q3 		$1K Hold
300
– – ﹤0.01% 200
2015
Q2 		$1K Hold
300
– – ﹤0.01% 204
2015
Q1 		$1K Hold
300
– – ﹤0.01% 206
2014
Q4 		$1K Hold
300
– – ﹤0.01% 209
2014
Q3 		$1K Hold
300
– – ﹤0.01% 210
2014
Q2 		$1K Hold
300
– – ﹤0.01% 210
2014
Q1 		$1K Hold
300
– – ﹤0.01% 210
2013
Q4 		$1K Hold
300
– – ﹤0.01% 211
2013
Q3 		$2K Sell
300
-135
-31% -$777 ﹤0.01% 204
2013
Q2 		$2K Buy
+435
New +$1.43K ﹤0.01% 207

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Markston International's IMMU Position: Q4 2015 in Review

Markston International sold out of Immunomedics Inc (IMMU) in Q4 2015, closing a stake of 300 shares — an estimated $1K sold.

Markston International first reported a position in IMMU in Q2 2013 and held it in 10 quarters. The position peaked at $2K in Q3 2013. 92 funds tracked by Wall St. Rank hold IMMU as of Q4 2015.

  • Markston International reported no remaining Immunomedics Inc position as of Q4 2015 after selling out during the quarter.
  • Markston International sold 300 Immunomedics Inc shares in Q4 2015, an estimated $1K.
  • Markston International first reported a position in Immunomedics Inc in Q2 2013 and held it in 10 quarters.
  • Markston International's Immunomedics Inc position peaked at $2K in Q3 2013.
  • 92 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2015.

Based on Markston International's 13F filing for Q4 2015, filed 8 Feb 2016.